Exchange Agreement regarding Working Capital Notes and Extension Notes, by and among the Company, Purchaser, Docter and I-fa Chang, dated April 8, 2025

Exhibit 10.1

EXCHANGE AGREEMENT

This Exchange Agreement (this “Agreement”) is entered into as of April 8, 2025 (the “Effective Date”) by and among Aimfinity Investment Corp. I, a Cayman Islands exempted company (the “SPAC”), Aimfinity Investment Merger Sub I, a Cayman Islands exempted company (“PubCo”), Docter Inc., a Delaware corporation (“Target”), and I-Fa Chang, a Taiwanese national (the “Holder”).

WHEREAS, the SPAC, PubCo, Target and Aimfinity Investment Merger Sub II, Inc., a Delaware subsidiary of the PubCo, have entered into an agreement and plan of merger (as amended from time to time, the “Merger Agreement”) providing for the business combination between the SPAC and the Target (the “Business Combination”);

WHEREAS, at the closing of the Business Combination, Docter will become wholly owned subsidiary of PubCo and the PubCo shall be renamed as “Inkwater Holding Inc.”;

WHEREAS, as of the date hereof, the SPAC has issued the following promissory note to the Holder:

(a) 1 promissory note, dated December 8, 2023 (the “Note 1”), the form of which is set forth in Exhibit A, pursuant to which the Holder would loan the SPAC up to $500,000 to be used as working capital of the SPAC;

(b) 1 promissory note, dated April 4, 2024 (the “Note 2”), with the same terms as Note 1 except as to the date of the note, pursuant to which the Holder would loan the SPAC up to $500,000 to be used as working capital of the SPAC;

(c) 1 promissory note, dated October 21, 2024 (the “Note 3”, together with Note 1 and Note 2, the “Working Capital Notes”), with the same terms as Note 1 except as to the date of the note and the amount, pursuant to which the Holder would loan the SPAC up to $1,500,000 to be used as working capital of the SPAC;

(d) 9 promissory notes, from July 2023 to March 2024, each (a “First EGM Extension Note”) in the amount of $85,000 with substantially the same terms as set forth in the form in Exhibit B, pursuant to which the Holder deposited $85,000 for each month to the trust account (the “Trust Account”) of the SPAC, maintained by U.S. Bank, N.A. as the trustee for the benefits of the public shareholders of the SPAC, to allow the SPAC to extend its deadline for completing an initial business combination for 9 one-month extensions from July 28, 2023 to April 28, 2024;

(e) 9 promissory notes, from April 2024 to December 2024, each (a “Second EGM Extension Note”) in the amount of $60,000 with substantially the same terms as set forth in the form in Exhibit C, pursuant to which the Holder deposited $60,000 for each month to the Trust Account, to allow the SPAC to extend its deadline for completing an initial business combination for 9 one-month extensions from April 28, 2024 to January 28, 2025;

(f) 3 promissory notes, from January 2024 to March 2024, each (a “Third EGM Extension Note”, together with all First EGM Extension Notes and Second EGM Extension Notes, the “Extension Notes”) issued to Mr. Chang in the amount of $55,823.80 with substantially the same terms as set forth in the form in Exhibit D, pursuant to which the Holder deposited $55,823.80 for each month to the Trust Account, to allow the SPAC to extend its deadline for completing an initial business combination for 3 one-month extensions from January 28, 2025 to April 28, 2025;

WHEREAS, as of February 28, 2025, an aggregate of $1,202,852 of working capital loans have been outstanding and accrued under the Working Capital Notes (together with the Extension Notes, the “SPAC Notes”), and further working capital loans has been provided and may be further provided by the Holder to the SPAC under the Working Capital Notes between February 28, 2025 and the closing of the Business Combination, which have yet to be accounted for and accrued on the capital account of the SPAC at this time.

WHEREAS, as of March 28, 2025, an aggregate of $1,472,471.40 of extension payments have been outstanding and accrued under the Extension Notes.

WHEREAS, as provided in the final prospectus (the “Final Prospectus”) of the SPAC filed with the U.S. Securities and Exchange Commission (File No. 333-263874) in connection with the initial public offering of the SPAC, the directors, officers, Aimfinity Investment LLC (the “Sponsor”), or the affiliates or designees of the foregoing may loan working capital to the Company, in exchange for the receipt of promissory notes to be issued to such persons, enabling such persons to convert such promissory notes, in whole or in part, into private units (the “Private Units”) of the SPAC, that are identical to The Private Units issued by the SPAC in the private placement consummated simultaneously with the SPAC’s initial public offering, with such conversion being an amount determined by dividing (x) the sum of the outstanding principal amount payable to such persons by (y) $10.00, although such issued Private Units shall not exceed 150,000 Private Units.

WHEREAS, pursuant to Section 9.6 of the Merger Agreement, the Parties hereto intend to enter into this agreement as a Transaction Financing (as defined in the Merger Agreement) to support and facilitate the closing of the Business Combination;

WHEREAS, in connection with the closing of the Business Combination, the Parties hereto wish to: (x) pursuant to the Final Prospectus, exchange all $1,472,471.40 of extension payments under the Extension Notes and $27,528.60 of working capital loans under the Working Capital Notes for 150,000 Private Units of the SPAC, as of the date hereof, which shall be converted into 150,000 ordinary shares of PubCo, par value $0.001 (the “Ordinary Shares”), and 225,000 warrants of PubCo; (y) exchange any remaining portion of the working capital loans that remain outstanding as of the closing of the Business Combination, less the $27,528.60 exchanged as of the date hereof, to such number of Ordinary Shares (the “Repayment Shares”), at an exchange rate of $10.00 per share, with a fraction of an ordinary Share rounded down to the nearest whole number.

NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged by the parties hereto, the parties hereto agree as follows:

[Signature Pages Follow]

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

7